L. P. Lau

Future of Rare Diseases Research 2017–2027: An IRDiRC Perspective

Christine M. Cutillo, S. Terry, C. Austin, 2017, Clinical and translational science.

‘IRDiRC Recognized Resources': a new mechanism to support scientists to conduct efficient, high-quality research for rare diseases

Christopher P Austin, Hanns Lochmüller, Kym M Boycott, 2016, European Journal of Human Genetics.

Progress in Rare Diseases Research 2010–2016: An IRDiRC Perspective

Christine M. Cutillo, C. Austin, P. Kaufmann, 2017, Clinical and translational science.

The International Rare Diseases Research Consortium: Policies and Guidelines to maximize impact

C. Austin, P. Kaufmann, P. Lasko, 2017, European Journal of Human Genetics.

International collaborative actions and transparency to understand, diagnose, and develop therapies for rare diseases

Christine M. Cutillo, C. Austin, K. Boycott, 2019, EMBO molecular medicine.

The International Rare Diseases Research Consortium: Policies and Guidelines to maximize impact

C. Austin, P. Kaufmann, P. Lasko, 2017, European Journal of Human Genetics.

‘IRDiRC Recognized Resources’: a new mechanism to support scientists to conduct efficient, high-quality research for rare diseases

P. Kaufmann, Hanns Lochmüller, K. Boycott, 2016, European Journal of Human Genetics.

The importance of international collaboration for rare diseases research: a European perspective

Christine M. Cutillo, C. Austin, A. Rath, 2017, Gene Therapy.